Skip to main content

and
  1. Article

    Erratum: Acquired resistance to zoledronic acid and the parallel acquisition of an aggressive phenotype are mediated by p38-MAP kinase activation in prostate cancer cells

    Correction to: Cell Death and Disease (2013) 4, e641; doi:10.1038/cddis.2013.165; published online 23 May 2013 Since the publication of this paper the authors have noticed the blots in Figure 5c displaying p-P...

    M R Milone, B Pucci, F Bruzzese, C Carbone, G Piro, S Costantini in Cell Death & Disease (2014)

  2. Article

    Open Access

    Acquired resistance to zoledronic acid and the parallel acquisition of an aggressive phenotype are mediated by p38-MAP kinase activation in prostate cancer cells

    The nitrogen-containing bisphosphonates (N-BP) zoledronic acid (ZOL) inhibits osteoclast-mediated bone resorption, and it is used to prevent skeletal complications from bone metastases. ZOL has also demonstrat...

    M R Milone, B Pucci, F Bruzzese, C Carbone, G Piro, S Costantini in Cell Death & Disease (2013)

  3. No Access

    Article

    IL-10 expression by CT26 colon carcinoma cells inhibits their malignant phenotype and induces a T cell-mediated tumor rejection in the context of a systemic Th2 response

    In spite of the evidence that IL-10 has Th1-immunosuppressive and anti-inflammatory effects, it has been shown that IL-10 may reduce the tumorigenic capacity of certain tumor cell types. In order to characteri...

    S K Adris, S Klein, M A Jasnis, E Chuluyan, M F Ledda, A I Bravo, C Carbone in Gene Therapy (1999)